FMP
NASDAQ
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
3.13 USD
-0.015 (-0.48%)
Valuation Date:
Apr 19, 2024 12:54 PM
Share Price on Valuation Date
$3.13
Stock Beta
0.47
Shares Outstanding
11395100